News: November 2017

Exploring the economics of sight-saving technology

Over two million people in the UK are living with sight loss. This will double to nearly four million people by 2050 as the population ages and underlying causes like obesity and diabetes increase. This places huge pressure on NHS eye care services. 

The 2016 Royal National Institute for the Blind (RNIB) report highlighted that sight loss is estimated to cost over £28 billion to the UK economy.

Research into new sight-saving technology could improve the lives of people at risk of sight loss and provide saving to the NHS and wider economy.

Two researchers from Centre for Health Economics and Medicines Evaluation CHEME,  are co-investigators on the optical coherence tomography (OCT) study, which has been awarded £1.3 million of funding from the National Institute for Health Research (NIHR) Invention for Innovation (i4i) Programme. 

Publication date: 23 November 2017

Poster award for CHEME at International Society for Pharmaco Economic and Outcomes Research (ISPOR) conference

Members of the pharmacoeconomics and medicines evaluation section of the Centre for Health Economics and Medicines Evaluation (CHEME) attended the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress at Glasgow on the 6th-8th November.

Publication date: 15 November 2017